Daniel L. Alkon - Dec 16, 2022 Form 4 Insider Report for Synaptogenix, Inc. (SNPX)

Role
President and CSO, Director
Signature
/s/ Robert Weinstein, Attorney-in-fact
Stock symbol
SNPX
Transactions as of
Dec 16, 2022
Transactions value $
-$23,072
Form type
4
Date filed
12/20/2022, 07:01 PM
Previous filing
Dec 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNPX Common Stock, par value $0.0001 per share Sale -$23.1K -19.7K -35.64% $1.17 35.5K Dec 16, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 sales plan, entered into on December 6, 2021 and amended and restated on October 24, 2022, to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.